NEGI, Deepika, Simon GRANAK, Susan SHORTER, Valerie B LEARY, Ivan REKTOR and Saak V OVSEPIAN. Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases. NEUROTHERAPEUTICS. UNITED STATES: SPRINGER, 2023, vol. 20, No 3, p. 767-778. ISSN 1933-7213. Available from: https://dx.doi.org/10.1007/s13311-023-01355-7.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases
Authors NEGI, Deepika, Simon GRANAK, Susan SHORTER, Valerie B LEARY, Ivan REKTOR (203 Czech Republic, belonging to the institution) and Saak V OVSEPIAN (guarantor).
Edition NEUROTHERAPEUTICS, UNITED STATES, SPRINGER, 2023, 1933-7213.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.700 in 2022
RIV identification code RIV/00216224:14740/23:00133507
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1007/s13311-023-01355-7
UT WoS 000945760600001
Keywords in English Epileptic seizures; Neurodegeneration; Fluid biomarkers; Neurofilament light chain; Tau protein; Axonal degeneration; Neurogranin
Tags 14110127, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 5/3/2024 13:10.
Abstract
In neurodegenerative diseases, changes in neuronal proteins in the cerebrospinal fluid and blood are viewed as potential biomarkers of the primary pathology in the central nervous system (CNS). Recent reports suggest, however, that level of neuronal proteins in fluids also alters in several types of epilepsy in various age groups, including children. With increasing evidence supporting clinical and sub-clinical seizures in Alzheimer's disease, Lewy body dementia, Parkinson's disease, and in other less common neurodegenerative conditions, these findings call into question the specificity of neuronal protein response to neurodegenerative process and urge analysis of the effects of concomitant epilepsy and other comorbidities. In this article, we revisit the evidence for alterations in neuronal proteins in the blood and cerebrospinal fluid associated with epilepsy with and without neurodegenerative diseases. We discuss shared and distinctive characteristics of changes in neuronal markers, review their neurobiological mechanisms, and consider the emerging opportunities and challenges for their future research and diagnostic use.
PrintDisplayed: 20/7/2024 02:33